1-2 of 2
Keywords: Survival rates
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome

Available to Purchase
Subject Area:
Further Areas
Serkan Keskin, Faruk Taş, Sezai Vatansever
Journal: Urologia Internationalis
Urol Int (2013) 90 (4): 435–438.
https://doi.org/10.1159/000345489
Published Online: 18 January 2013
... investigated the role of two different mitotane-containing regimens for the treatment of patients with advanced AC. They reported that response and progression-free survival rates were significantly better with EDP (etoposide, doxorubicin and cisplatin) and mitotane than with streptozocin and mitotane...
View article titled, Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome
Open the PDF for Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome in another window
Journal Articles

Methods and Prognosis of the Extirpation of Pulmonary Metastases following Tumor Nephrectomy

Available to Purchase
Subject Area:
Further Areas
G. Schott, J. Weissmüller, E. Vecera
Journal: Urologia Internationalis
Urol Int (1988) 43 (5): 272–274.
https://doi.org/10.1159/000281353
Published Online: 29 January 2010
...G. Schott; J. Weissmüller; E. Vecera Nephrectomy was performed in 938 patients with renal carcinoma between the years 1960 and 1986. The cumulative survival rate was 78.7 ± 2.7% after 1 year; 62.9 ± 3.2% after 3 years; 52.4 ± 3.5% after 5 years, and 38.0 ± 4.1% after 10 years. Of this group, 39...
View article titled, Methods and Prognosis of the Extirpation of Pulmonary Metastases following Tumor Nephrectomy
Open the PDF for Methods and Prognosis of the Extirpation of Pulmonary Metastases following Tumor Nephrectomy in another window